Summary of Product Characteristics
last updated on the eMC:
07/07/2005
Go to top of the page | Occlusal. 26% w/w cutaneous solution | |
Go to top of the page | Salicylic Acid 26% w/w. For excipients, see 6.1 | |
Go to top of the page | Cutaneous solution A colourless to pale yellow solution with a characteristic smell of nail varnish | |
Go to top of the pageGo to top of the page | Occlusal is indicated for the treatment and removal of common and plantar warts (verrucae). | |
Go to top of the page | For topical application.Prior to application soak wart in warm water for five minutes. Remove loose tissue with a brush, emery board, pumice or abrasive sponge, being careful to avoid causing pin-point bleeding or abrading the surrounding healthy skin. Dry thoroughly with a towel not used by others to avoid contagion. Carefully apply Occlusal twice to the wart using the brush applicator allowing the first application to dry before applying the second. Thereafter repeat treatment once daily or as directed by physician. Do not apply to surrounding healthy skin. Clinically visible improvement should occur in one to two weeks but maximum effect may be expected after four to six weeks.There are no differences in dosage for children, adults or the elderly. | |
Go to top of the page | Occlusal should not be used by diabetics or patients with impaired blood circulation. Do not use on moles, birthmarks, unusual warts with hair growth, on facial warts, or in the anal or perineal region. | |
Go to top of the page | Occlusal is for external use only. Do not permit contact with eyes or mucous membranes. If contact occurs flush with water for 15 minutes. Do not allow contact with normal skin around wart. Avoid using on areas of broken or damaged skin. Discontinue treatment if excessive irritation occurs. | |
Go to top of the pageGo to top of the page | The chronic use of this product during pregnancy and lactation, particularly when large areas of skin are involved, should be avoided. | |
Go to top of the pageGo to top of the page | A localised irritant reaction may occur if Occlusal is applied to normal skin surrounding the wart. This may normally be controlled by temporarily discontinuing the use of Occlusal and by being careful to apply the solution only to the wart itself when treatment is resumed. | |
Go to top of the page | Salicylism can occur following large doses of salicylic acid or prolonged use of topical salicylic preparations, or in the unlikely event of accidental consumption. | |
Go to top of the pageGo to top of the page | Salicylic acid has bacteriostatic and fungicidal actions, but it is its keratolytic properties which are important for this medicinal product. When applied externally it produces slow and painless destruction of the epithelium. Salicylic acid is usually applied in the form of a paint in a collodian base (10 to 17%) or as a plaster (20 to 50%) to destroy warts or corns. | |
Go to top of the pageGo to top of the pageGo to top of the pageGo to top of the page | Polyvinyl butyralDibutyl phthalateIsopropyl alcoholButyl acetateAcrylates copolymer | |
Go to top of the pageGo to top of the pageGo to top of the pageGo to top of the page | The product is presented in a 10ml amber glass bottle with cap brush assembly. The cap brush assembly comprises of a black cap and a white polythene wand nylon brush with stainless steel staple. | |
Go to top of the page | Occlusal is flammable and should be kept away from flame or fire. Keep the bottle tightly capped when not in use. Do not allow the solution to drip from the brush onto the bottle neck thread, otherwise subsequent opening of the bottle may be difficult. | |
Go to top of the page | Alliance Pharmaceuticals Limited Avonbridge House 2 Bath Road Chippenham Wiltshire, SN15 2BB UK | |
Go to top of the pageGo to top of the page | 7th September 1998/18th May 2005 | |
Go to top of the page
More information about this product
Link to this document from your website: http://emc.medicines.org.uk/medicine/15317/SPC/Occlusal/